IMI Conference Presentations
Welcome to our Latest Opportunities & News Section!
Please click on any of the news listed for further information.
Biopharma leaders unite to stand with science
Johnson & Johnson announces that Janssen's COVID-19 investigational vaccine candidate prevents severe clinical disease in pre-clinical studies
Don't fall for the 'next best action' trap
Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
Vitamin D deficiency may raise risk of getting COVID-19
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines
Steroid found to improve survival of critically ill COVID-19 patients
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.